PX1 Research delivers high-purity CJC-1295 No DAC and Ipamorelin compounds engineered exclusively for laboratory experimentation. Formulated to support preclinical investigations into growth hormone receptor signaling and tissue repair pathways, our research products undergo rigorous third-party verification to ensure lot-to-lot consistency. Qualified institutions can buy CJC Ipamorelin research peptide vials with verified certificates of analysis and same-day dispatch from our California and Arizona fulfillment hubs.
PX1 Research delivers high-purity CJC-1295 No DAC and Ipamorelin compounds engineered exclusively for laboratory experimentation. Formulated to support preclinical investigations into growth hormone receptor signaling and tissue repair pathways, our research products undergo rigorous third-party verification to ensure lot-to-lot consistency. Qualified institutions can buy CJC Ipamorelin research peptide vials with verified certificates of analysis and same-day dispatch from our California and Arizona fulfillment hubs.
To buy CJC Ipamorelin research peptide compounds for laboratory evaluation, researchers require validated purity, precise molecular mass identification, and full batch traceability. CJC-1295 No DAC (Modified GRF 1-29) acts as a growth-hormone-releasing hormone (GHRH) analog, while Ipamorelin functions as a selective ghrelin/growth hormone secretagogue receptor (GHSR-1a) agonist. When combined in vitro or in animal models, these peptides demonstrate complimentary signaling that amplifies pulsatile growth hormone (GH) secretion and downstream insulin-like growth factor 1 (IGF-1) expression for tissue repair research.
PX1 Research supplies USA-manufactured cjc ipamorelin research products verified via high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS). Every vial is produced in GMP-compliant, ISO 17025-accredited facilities to prevent cross-contamination and guarantee active concentration. Orders placed before 12 PM PST ship same-day from our CA and AZ facilities, providing research institutions with rapid access to verified compounds for cellular assays and preclinical protocols.
The co-administration of GHRH analogs and GHSR agonists represents a primary focus in neuroendocrine signaling research. Preclinical models indicate that somatotroph cells in the anterior pituitary express distinct surface receptors for GHRH and ghrelin. When researchers utilize a dual-peptide approach, CJC-1295 binds to the GHRH receptor, initiating intracellular cAMP accumulation via adenylate cyclase activation. Simultaneously, Ipamorelin activates GHSR-1a, mobilizing intracellular calcium ions through the phospholipase C (PLC) pathway.
This dual-pathway stimulation yields a synergistic amplification of GH release without prematurely depleting pituitary stores. In vitro assays demonstrate that co-incubating pituitary cell cultures with both peptides results in a significantly greater GH release amplitude than the additive total of either peptide administered in isolation. Investigating this pathway provides valuable data on receptor crosstalk, receptor desensitization kinetics, and downstream IGF-1 transcription in peripheral tissues. Researchers exploring these pathways can review broader secretagogue mechanisms in our growth hormone secretagogues guide.
Sourcing reliable cjc ipamorelin research products requires evaluating critical analytical benchmarks. Inconsistent synthesis parameters or inadequate purification can introduce truncated peptide sequences, residual coupling reagents, or endotoxin contamination that corrupts cell culture experiments and invalidates receptor binding studies.
PX1 Research enforces stringent quality control parameters across every production batch to protect lab integrity:
• Purity Verification: Reverse-Phase HPLC analysis confirming ≥98% peptide purity, eliminating truncated sequence artifacts. • Mass Identification: Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization (ESI-MS) confirming exact molecular weight. • Endotoxin Screening: Chromogenic LAL assay ensuring endotoxin levels remain below strictly defined limits (typically <0.05 EU/mg) for cellular compatibility. • Domestic Production: Synthesized exclusively in US-based GMP-compliant facilities following ISO 17025 laboratory quality management frameworks. • Lot Traceability & Shipping: Fully traceable lot numbers backed by downloadable COAs, shipped same-day M–F from CA and AZ warehouses.
The cjc-1295 no dac research peptide, also known as Modified GRF 1-29, is a 29-amino-acid synthetic peptide corresponding to the amino-terminal fragment of endogenous GHRH, modified at positions 2, 8, 15, and 27. These specific amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) confer enhanced resistance to dipeptidyl peptidase-IV (DPP-IV) cleavage relative to native GHRH 1-29.
Unlike the Drug Affinity Complex (DAC) variant—which covalently binds to serum albumin to extend its half-life to several days—CJC-1295 No DAC exhibits a shorter biological half-life (approximately 30 minutes in animal models). This rapid clearance profile closely mirrors physiological GHRH pulsatility. Preclinical research indicates that CJC-1295 No DAC sustains elevated GH and downstream IGF-1 levels without inducing continuous, non-physiological receptor saturation, making it an ideal candidate for studying physiological tissue repair mechanisms. Learn more about GHRH peptide modifications in our detailed GHRH analogs guide.
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) engineered to exhibit high selectivity for the growth hormone secretagogue receptor (GHSR-1a). In rodent and non-human primate models, Ipamorelin selectively stimulates pituitary somatotrophs to release GH without evoking secondary endocrine responses.
Unlike earlier growth hormone releasing peptides (such as GHRP-6 or GHRP-2), ipamorelin does not significantly elevate plasma cortisol, adrenocorticotropic hormone (ACTH), or prolactin levels during in vitro or in vivo trials. This selectivity permits researchers to isolate GH signaling cascades from confounding glucocorticoid or prolactin activity. Investigating Ipamorelin in cell culture models allows researchers to analyze ghrelin receptor binding affinities, intracellular calcium flux, and target gene expression related to lipid metabolism and cellular regeneration.
Evaluating secretagogue candidates requires understanding their structural, kinetic, and receptor affinity differences across the research peptide spectrum. The table below outlines key parameters across primary GHRH analogs and secretagogues used in preclinical studies.
When comparing GHRH analogs, CJC-1295 No DAC provides natural pulsatile kinetics, whereas long-acting analogs like tesamorelin exhibit specialized binding profiles studied primarily for visceral adiposity and metabolic signaling. Furthermore, basic GHRH fragments like sermorelin possess shorter half-lives due to rapid enzymatic degradation by DPP-IV. For a deeper technical breakdown, consult our tesamorelin vs cjc-1295 comparative analysis.
Proper handling of lyophilized peptide vials is critical to maintaining secondary structure and preventing enzymatic breakdown prior to assay setup. Lyophilized CJC-1295 No DAC and Ipamorelin should be stored at -20°C or -80°C upon receipt to maintain long-term stability.
For reconstitution in laboratory environments, researchers should strictly utilize sterile bacteriostatic water (0.9% benzyl alcohol) or sterile endotoxin-free water depending on cell culture sensitivity. Reconstitution procedures should involve gently aiming the solvent along the glass inner wall of the vial, allowing the solvent to hydrate the cake slowly without vigorous vortexing, which can denature the peptide structure. Once reconstituted, liquid solutions must be aliquoted to avoid repeated freeze-thaw cycles and maintained at 2°C to 8°C for short-term experimentation. Review complete laboratory handling protocols in our peptides research portal.
Independent verification of purity and identity is essential when publishing reproducible scientific data. PX1 Research subjects every batch of CJC-1295 and Ipamorelin to dual-stage analytical testing through an ISO 17025 accredited laboratory.
High-Performance Liquid Chromatography (RP-HPLC) measures the relative area percentage of the primary peptide peak against synthesis impurities, ensuring a minimum baseline purity of 98.0%. Mass Spectrometry (ESI-MS or MALDI-TOF) verifies the exact molecular mass against theoretical sequence expectations (CJC-1295 No DAC theoretical MW: 3367.9 Da; Ipamorelin theoretical MW: 711.9 Da). Additionally, quantitative Limulus Amebocyte Lysate (LAL) testing measures bacterial endotoxin levels to guarantee suitability for delicate in vitro assays and animal model administrations. Complete Certificates of Analysis are publicly available for every production lot.
Academic institutions, biotechnology laboratories, and contract research organizations (CROs) requiring large-volume peptide lots can utilize PX1 Research's institutional supply channels. We provide custom fill volumes, bulk lyophilized powder, and standardized dual-peptide combinations tailored to specific experimental parameters.
Institutional buyers benefit from tiered volume pricing, dedicated account management, and standardized lot reservation to ensure consistency across longitudinal studies. All institutional orders undergo the exact same HPLC/MS and endotoxin testing protocols as single-vial offerings. Learn more about establishing institutional supply agreements on our wholesale peptide portal.
Where can lab managers buy cjc ipamorelin research peptide lots with verified COAs?
Lab managers can buy CJC Ipamorelin research peptide lots directly through PX1 Research. Every batch is manufactured in the USA within GMP-compliant, ISO 17025 accredited facilities and includes downloadable, lot-specific Certificates of Analysis covering RP-HPLC purity, mass spectrometry, and endotoxin levels.
What distinguishes cjc ipamorelin research products from single-peptide formulations?
CJC Ipamorelin research products combine a GHRH analog (CJC-1295 No DAC) with a selective GHSR agonist (Ipamorelin). This dual-action approach targets two distinct pituitary receptor pathways simultaneously, allowing researchers to study synergistic growth hormone secretion in vitro and in animal models.
What is the mechanism of cjc-1295 no dac research peptide in pituitary cell culture?
The cjc-1295 no dac research peptide acts as a modified GHRH receptor agonist. In pituitary cell cultures, it binds to GHRH receptors on somatotrophs, activating adenylate cyclase to increase cAMP levels and stimulate the synthesis and pulsatile release of endogenous growth hormone.
What is the difference between CJC-1295 with DAC and CJC-1295 No DAC?
CJC-1295 with DAC includes a Drug Affinity Complex that covalently binds to plasma albumin, extending its biological half-life to several days in vivo. CJC-1295 No DAC lacks this complex, resulting in a half-life of roughly 30 minutes, which permits researchers to mimic natural physiological GH pulses without continuous receptor activation.
How does Ipamorelin selectively target the ghrelin receptor without increasing cortisol or prolactin?
Ipamorelin features a synthetic pentapeptide structure engineered specifically for high GHSR-1a binding selectivity. Unlike early secretagogues (GHRP-6, GHRP-2), preclinical studies demonstrate that Ipamorelin activates the PLC/calcium signaling cascade in somatotrophs without triggering the hypothalamic-pituitary-adrenal axis that elevates ACTH, cortisol, or prolactin.
How should lyophilized CJC-1295 and Ipamorelin be reconstituted in vitro?
Lyophilized CJC-1295 and Ipamorelin should be reconstituted using sterile bacteriostatic water or sterile endotoxin-free water. The solvent should be introduced slowly down the side of the glass vial to hydrate the lyophilized cake without aggressive shaking or vortexing, preserving the peptide structure.
What storage temperatures preserve peptide integrity post-reconstitution?
Lyophilized powder should be stored long-term at -20°C or -80°C. Once reconstituted, liquid solution aliquots should be refrigerated at 2°C to 8°C and used within 3 to 4 weeks to prevent peptide degradation, or stored frozen at -20°C for short extensions while avoiding repeated freeze-thaw cycles.
Why is endotoxin testing critical for CJC-1295 and Ipamorelin cellular assays?
Bacterial endotoxins (lipopolysaccharides) can provoke severe inflammatory responses in cell cultures and animal models, confounding experimental observations regarding cell viability, cytokine expression, and receptor signaling. PX1 Research tests every lot via chromogenic LAL assays to ensure endotoxins remain below strict laboratory limits.
How does CJC-1295 compare to Tesamorelin in animal models of IGF-1 expression?
In preclinical models, both CJC-1295 No DAC and Tesamorelin stimulate GHRH receptors to elevate GH and downstream IGF-1 levels. However, Tesamorelin contains a hexenoyl moiety that alters its stability and pharmacokinetic profile, primarily evaluated in research models of visceral adipose reduction, whereas CJC-1295 No DAC is widely used for pulsatile tissue repair studies.
Does PX1 Research offer same-day shipping on CJC-1295 and Ipamorelin products?
Yes. All standard research peptide orders—including CJC-1295 No DAC and Ipamorelin—placed before 12 PM PST Monday through Friday ship same-day from our fulfillment facilities located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.